Cargando…

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

BACKGROUND: Whether the addition of radiation therapy (RT) improves overall survival in men with locally advanced prostate cancer managed with androgen deprivation therapy (ADT) is unclear. Our aim was to compare outcomes in such patients with locally advanced prostate cancer. METHODS: Patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warde, Padraig, Mason, Malcolm, Ding, Keyue, Kirkbride, Peter, Brundage, Michael, Cowan, Richard, Gospodarowicz, Mary, Sanders, Karen, Kostashuk, Edmund, Swanson, Greg, Barber, Jim, Hiltz, Andrea, Parmar, Mahesh KB, Sathya, Jinka, Anderson, John, Hayter, Charles, Hetherington, John, Sydes, Matthew R, Parulekar, Wendy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lancet Publishing Group 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243932/ https://www.ncbi.nlm.nih.gov/pubmed/22056152 http://dx.doi.org/10.1016/S0140-6736(11)61095-7

Ejemplares similares

Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer
por: Mason, Malcolm D., et al.
Publicado: (2015)

Estimating the Impact of Randomised Control Trial Results on Clinical Practice: Results from a Survey and Modelling Study of Androgen Deprivation Therapy plus Radiotherapy for Locally Advanced Prostate Cancer
por: South, Annabelle, et al.
Publicado: (2016)

The need for a cultural shift from two-arm to multi-arm RCTS
por: Sydes, Matthew R, et al.
Publicado: (2013)

Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials
por: Dearnaley, David P, et al.
Publicado: (2009)

Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis
por: Rydzewska, Larysa H.M., et al.
Publicado: (2017)

The Capital Investment Strategy for Radiation therapy in Ontario: A Framework to Ensure Access to Radiation Therapy
por: Glicksman, Rachel M., et al.
Publicado: (2019)

A survey of radiation treatment planning peer-review activities in a provincial radiation oncology programme: current practice and future directions
por: Brundage, Michael, et al.
Publicado: (2013)

A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy
por: Alibhai, Shabbir MH, et al.
Publicado: (2015)

Defining the optimal treatment strategy for localized prostate cancer patients: a survey of ongoing studies at the National Cancer Institute of Canada Clinical Trials Group
por: Parulekar, W.R., et al.
Publicado: (2008)

A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy
por: Alibhai, Shabbir M. H., et al.
Publicado: (2019)

Sharing data from clinical trials: the rationale for a controlled access approach
por: Sydes, Matthew R, et al.
Publicado: (2015)

Differential gene expression and clonal selection during cellular transformation induced by adhesion deprivation
por: Jinka, Rajeswari, et al.
Publicado: (2010)

Image guided dose escalated prostate radiotherapy: still room to improve
por: Martin, Jarad M, et al.
Publicado: (2009)

Correction: Image guided dose escalated prostate radiotherapy: still room to improve
por: Martin, Jarad M, et al.
Publicado: (2009)

Adding new experimental arms to randomised clinical trials: Impact on error rates
por: Choodari-Oskooei, Babak, et al.
Publicado: (2020)

A framework for the design and analysis of phase III randomised trials in uncommon diseases
por: Parmar, Mahesh, et al.
Publicado: (2015)

[(18)F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial
por: Glicksman, Rachel M, et al.
Publicado: (2020)

Lenvatinib in multimodal therapy for unresectable radioactive iodine‐naïve differentiated thyroid cancer: A case report with literature review
por: Kim, Hugh Andrew Jinwook, et al.
Publicado: (2022)

The value of evidence synthesis in randomised controlled trial (RCT) design, conduct and analysis: MRC clinical trials unit (CTU) at UCL experience
por: Tierney, Jayne F, et al.
Publicado: (2015)

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial
por: James, Nicholas D, et al.
Publicado: (2012)

Survival analysis: coping with non proportional hazards in randomized trials
por: Royston, Patrick, et al.
Publicado: (2011)

An approach to trial design and analysis in the era of non-proportional hazards of the treatment effect
por: Royston, Patrick, et al.
Publicado: (2014)

Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome
por: Royston, Patrick, et al.
Publicado: (2013)

Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings
por: Noor, Nurulamin M., et al.
Publicado: (2020)

Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer
por: Marshall, Catherine H., et al.
Publicado: (2021)

Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated
por: Royston, Patrick, et al.
Publicado: (2016)

Opioid therapy vs. multimodal analgesia in head and neck Cancer (OPTIMAL-HN): study protocol for a randomized clinical trial
por: Zayed, Sondos, et al.
Publicado: (2021)

How do you design randomised trials for smaller populations? A framework
por: Parmar, Mahesh K. B., et al.
Publicado: (2016)

Cryosurgery Versus Primary Androgen Deprivation Therapy for Locally Recurrent Prostate Cancer After Primary Radiotherapy: A Propensity-Matched Survival Analysis
por: Bauman, Glenn, et al.
Publicado: (2020)

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
por: Sydes, Matthew R, et al.
Publicado: (2009)

A new measure of predictive ability for survival models
por: Choodari-Oskooei, Babak, et al.
Publicado: (2011)

Discrimination-based sample size calculations for multivariable prognostic models for time-to-event data
por: Jinks, Rachel C., et al.
Publicado: (2015)

Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework
por: Blenkinsop, Alexandra, et al.
Publicado: (2019)

Sclerokeratoplasty as the Therapy for Corneal Perforation due to Exposure and Neurotrophic Keratopathy
por: Rozycki, Radoslaw, et al.
Publicado: (2014)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Arginine deprivation therapy for malignant melanoma
por: Yoon, Jung-Ki, et al.
Publicado: (2012)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7v0gkk8252hime4h7eokg4rhu4